CalciMedica Inc reports results for the quarter ended March 31 - Earnings Summary
14/05/2025 12:59
CalciMedica Inc CALC.OQ reported a quarterly adjusted loss of 36 cents per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of 1 cents. The mean expectation of three analysts for the quarter was for a loss of 31 cents per share. Wall Street expected results to range from -43 cents to -14 cents per share. Reported revenue was zero; analysts expected zero. CalciMedica Inc's reported EPS for the quarter was a loss of 36 cents. The company reported a quarterly loss of $5.04 million. CalciMedica Inc shares had risen by 1.0% this quarter and lost 45.5% so far this year. FORECAST CHANGES In the last 30 days, there have been no earnings estimate revisions by analysts covering the company. RECOMMENDATIONS The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy" Wall Street's median 12-month price target for CalciMedica Inc is $15.50 This summary was machine generated from LSEG data May 14 at 11:59 a.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
| QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
| Mar. 31 2025 | -0.31 | -0.36 | Missed |
| Dec. 31 2024 | -0.35 | -0.38 | Missed |
| Sep. 30 2024 | -0.50 | -0.50 | Met |
| Jun. 30 2024 | -0.53 | -0.36 | Beat |